Control by the evoked potential of the brain stem of the administration of dibekacine in premature infants.
The administration of dibekacine to 10 newborn carriers of a germ infection--or staphylococcus, was controlled for auditory tolerance. The auditory threshold was controlled by the evoked potential of the brain stem. Medication never caused the threshold to change. The evolution of latency in waves J1, J3 and J5 could not be seen except in wave 1 where latency decreased, as can be seen in other premature infants of babies born at term.
D001309:Auditory Threshold / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D001933:Brain Stem / Q000187:drug effects* / Q000503:physiopathology; D003982:Dibekacin / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male
D003982:Dibekacin; D007612:Kanamycin